Nighthawk Biosciences, Inc. (NHWK) SEC Filing 8-K Material Event for the period ending Sunday, August 21, 2022

Nighthawk Biosciences, Inc.

CIK: 1476963 Ticker: NHWK

View differences made from one to another to evaluate Nighthawk Biosciences, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Nighthawk Biosciences, Inc..


Assess how Nighthawk Biosciences, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Nighthawk Biosciences, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 8-K Corporate News

Ticker: NHWK
CIK: 1476963
Form Type: 8-K Corporate News
Accession Number: 0001553350-22-000710
Submitted to the SEC: Mon Aug 22 2022 7:30:14 AM EST
Accepted by the SEC: Mon Aug 22 2022
Period: Sunday, August 21, 2022
Industry: Pharmaceutical Preparations
  1. Financial Exhibit
  2. Other Events

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: